Put CV Risks With Triptans in Perspective

December 2022

We’re getting questions about which patients should avoid triptans due to cardiovascular concerns.

Labeling says that triptans shouldn’t be used in patients with coronary artery disease, stroke, uncontrolled hypertension, etc.

This stems from the early 1990s when it was thought that MIs were caused by vasospasm. Patients with CV disease or uncontrolled hypertension were excluded from triptan trials.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote